De.Mem Ltd Posts Record H1 2026 Revenue as EBITDA Nearly Triples

De.mem Limited posted record H1 2026 results with revenue up 26% to $17.6m and adjusted EBITDA surging 185% — here's what the numbers mean for investors eyeing the De.mem record half year results.
By Josua Ferreira -
  • De.mem delivered record H1 2026 revenue of $17.6m (up 26%) and adjusted EBITDA of $1,582k (up 185%), with the six-month EBITDA figure roughly matching the entire CY 2025 result.
  • Cash receipts of $20.0m extended De.mem's streak to 29 consecutive quarters of growth versus prior corresponding periods, compounding at approximately 24% per annum since 2019.
  • Approximately 90% of cash receipts are recurring, underpinned by Build, Own, Operate contracts, membrane replacements, specialty chemicals, and maintenance services across Singapore, Germany, and Australia.
  • The Western Australian segment — including recently acquired Core Chemicals — contributed approximately 49% of group revenues, with new clients won post-acquisition and additional prospects being quoted.
  • De.mem has guided for record full calendar year 2026 results, with the domestic water filtration launch, Australian WaterMark certification expected in CY 2026, and a new ~$100k per annum Singapore order adding incremental growth vectors.
Summarise with AI:

Record H1 2026 result marks strongest half-year in company history

In its financial report for the six months ended 30 June 2026 (H1 2026), De.mem Limited recorded the strongest half-year performance in its history, with growth achieved alongside a sharp lift in profitability.

The Australian-headquartered international water and waste water treatment company, with operations in Singapore and Germany, delivered record revenue of $17.6m (up 26% pcp), cash receipts of $20.0m (up 28% pcp), and adjusted EBITDA of $1,582k (up 185%), nearly tripling the prior corresponding period result.

H1 2026 results: record numbers across every key metric

De.mem reported records across all key financial metrics for the period, a combination that reflects revenue growth achieved whilst increasing profitability.

H1 2026 Key Financial Metrics Comparison

Adjusted EBITDA reached $1,582k, up 185% on $556k in H1 2025. The company noted it generated roughly the same adjusted EBITDA in the first six months of 2026 as it did across the full CY 2025. Operating cash flow followed a similar trajectory, coming in at $928k for the half compared with $318k for the whole of CY 2025.

Gross margin held at a strong 41%, and the company ended the period with $4.3m in cash and term deposits.

Metric H1 2026 H1 2025 Change Note
Revenue $17.6m $14.0m +26% Record half-year
Cash receipts $20.0m $15.7m +28% 29 consecutive quarters of growth
Adjusted EBITDA $1,582k $556k +185% ~Equal to full CY 2025
Gross margin 41% Up from 18% in 2017
Cash & term deposits $4.3m As at 30 June 2026

Adjusted EBITDA is defined as EBITDA adjusted to exclude one-off expenses such as business acquisition costs and share-based payments.

29 consecutive quarters of growth and a high-margin recurring model

The result extended a long growth track record. De.mem recorded 29 consecutive quarters of cash receipts growth versus prior corresponding periods, and has compounded cash receipts at approximately 24% per annum since 2019.

Underpinning that durability is a recurring revenue base representing approximately 90% of cash receipts, which the company said provides strong cash flow visibility. Gross margin progression tells a parallel story, rising from 18% in 2017 to 41% in H1 2026 as the business shifted toward higher-margin recurring segments.

De.mem’s full-year CY 2025 results marked the company’s first full calendar year of positive adjusted EBITDA, with gross margin reaching 43% by year-end, providing the profitability foundation that the H1 2026 period has now built upon.

Recurring revenue segments include:

  • Build, Own, Operate and Operations & Maintenance contracts
  • Regular maintenance work on water treatment equipment
  • Membrane replacement sales into existing facilities
  • Specialty chemicals sales through De.mem-Capic and other subsidiaries
  • Sales of pumps and related maintenance services
  • Sales of small equipment and consumables
  • Domestic water treatment systems and membrane cartridge sales

This recurring revenue base provides strong cash flow visibility and supports the Company’s record CY 2026 outlook.

Operating engines: Western Australia, Germany and domestic filtration

Western Australian specialty chemicals business

De.mem’s Western Australian business contributed approximately 49% of group revenues in H1 2026, forming a strong, cash-generating core. The segment includes recently acquired Core Chemicals Pty Ltd alongside De.mem-Capic Pty Ltd and Auswater Systems Pty Ltd.

Core Chemicals, whose acquisition completed on 31 October 2025, supplies specialty chemicals for gold fragment extraction and recovery from the refining waste stream to Western Australian gold mining clients. The company has won new clients since the acquisition and is actively quoting additional prospects, demonstrating cross-selling across the enlarged customer base.

German subsidiary De.mem-Geutec GmbH

The German subsidiary De.mem-Geutec GmbH delivered record revenue of approximately $2.5m in H1 2026. The performance was driven by a robust services and chemicals business combined with the delivery of a waste water treatment equipment project awarded to De.mem in late CY 2025.

Domestic water filtration launch

De.mem continued the ongoing launch of domestic water treatment products built around its Graphene-Oxide enhanced hollow fibre membrane technology, which received American NSF product certification in 2024.

The global domestic water filtration market was estimated at US$12.1 billion in 2022 and is expected to grow by 10.5% per annum to US$26.7 billion by 2030, according to Grand View Research, with Asia-Pacific the largest regional market. During the half, the company received an initial Singapore order estimated to be worth approximately $100k per annum.

The Australian WaterMark certification process is in progress, with conclusion expected in CY 2026. Subject to successful finalisation, De.mem would be able to promote its domestic filtration products for drinking water applications in Australia.

Acquisition track record and the road to record CY 2026

De.mem’s growth has been supported by disciplined M&A. The company reported 70% average revenue growth across six acquisitions completed between 2019 and 2024, per its Investor Presentation lodged with the ASX on 7 August 2026 (slide 14). Operating in a highly fragmented sector, it sees continued consolidation opportunity.

Looking ahead, De.mem said it expects continued strong performance in H2 2026 and is on track for record full calendar year 2026 results, supported by:

  1. Record H1 2026 results providing a solid foundation, with approximately 90% recurring revenues
  2. A strong and growing cash balance
  3. Growth momentum across 29 consecutive quarters
  4. A 24% cash receipts CAGR over the past seven years
  5. Double-digit organic growth momentum
  6. Continued contribution from the Western Australian business, including Core Chemicals (~49% of revenue)
  7. Record performance from German subsidiary De.mem-Geutec (~$2.5m revenue)
  8. Ongoing domestic filtration launch, including the new ~$100k p.a. Singapore business

This outlook reflects the company’s expectations rather than a guaranteed result, with forward performance subject to the usual market and operational risks.

CEO Andreas Kroell on the result

Andreas Kroell, Chief Executive Officer, De.mem Limited

“I am delighted to report our strongest half-year results in the Company’s history. We have been able to deliver significantly positive half-year EBITDA of approximately $1.6m, nearly tripling the result from prior corresponding period, as well as strong operating cash flows. Our record revenue growth of 26% and cash receipts growth of 28% demonstrate the success of our strategic focus on recurring revenue segments and operational excellence. With over 90% recurring revenues, strong cash generation, and exciting growth opportunities in industrial and domestic water treatment markets, we are well positioned to continue delivering record results for shareholders. Our strong first half performance, combined with the full-year contribution from recent acquisitions and progress in new markets, positions us well for continued growth in the second half and beyond.”

Don’t Miss the Next ASX Utilities Winner

Big News Blast delivers FREE breaking ASX news straight to your inbox within minutes of release, complete with in-depth analysis already done for you. Join 20,000+ subscribers who stay ahead of the market the moment announcements drop. Click the “Free Alerts” button to start receiving alerts across ASX utilities and beyond.


Frequently Asked Questions

What were De.mem's H1 2026 financial results?

De.mem reported record revenue of $17.6 million (up 26% on the prior corresponding period), cash receipts of $20.0 million (up 28%), and adjusted EBITDA of $1,582k (up 185%) for the six months ended 30 June 2026 — the strongest half-year in the company's history.

What does De.mem's 90% recurring revenue mean for investors?

Approximately 90% of De.mem's cash receipts come from recurring sources such as Build, Own, Operate contracts, membrane replacements, specialty chemicals, and maintenance services, which provides strong forward cash flow visibility and reduces reliance on one-off project wins.

What is De.mem's outlook for full-year CY 2026?

De.mem has guided for record full calendar year 2026 results, citing its strong H1 foundation, 29 consecutive quarters of cash receipts growth, continued contribution from its Western Australian business, record performance from its German subsidiary, and the ongoing domestic water filtration launch.

What is De.mem's domestic water filtration product and which markets is it targeting?

De.mem is commercialising domestic water treatment products based on its Graphene-Oxide enhanced hollow fibre membrane technology, which received American NSF certification in 2024. The company has received an initial Singapore order worth approximately $100k per annum and is pursuing Australian WaterMark certification, expected to conclude in CY 2026, to enable sales for drinking water applications in Australia.

How has De.mem grown through acquisitions?

De.mem completed six acquisitions between 2019 and 2024, delivering an average revenue growth of 70% per acquisition, with its most recent deal — Core Chemicals Pty Ltd, completed in October 2025 — now contributing approximately 49% of group revenues through the Western Australian segment.

Josua Ferreira
By Josua Ferreira
Partnership Director
Josua Ferreira holds a Bachelor of Commerce in Marketing and Advertising and brings a background in publication, business development, and ASX market storytelling. He has worked with listed companies across the resource sector and broader market, combining sharp commercial instincts with a genuine commitment to keeping investors informed.
Learn More
Companies Mentioned in Article

Breaking ASX Alerts Direct to Your Inbox

Join +20,000 subscribers receiving alerts.

Join thousands of investors who rely on StockWire X for timely, accurate market intelligence.

About the Publisher